Filing Details
- Accession Number:
- 0001181431-13-050844
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-09-27 14:43:34
- Reporting Period:
- 2013-09-23
- Filing Date:
- 2013-09-27
- Accepted Time:
- 2013-09-27 14:43:34
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1292519 | Invivo Therapeutics Holdings Corp. | NVIV | Surgical & Medical Instruments & Apparatus (3841) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1503383 | Francis Reynolds | 81 Lake Shore Rd. Salem NH 03079 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2013-09-23 | 12,000 | $1.40 | 11,391,920 | No | 4 | S | Direct | |
Common Stock | Disposition | 2013-09-23 | 400,000 | $0.00 | 10,991,920 | No | 5 | G | Direct | |
Common Stock | Disposition | 2013-09-24 | 12,000 | $1.47 | 10,979,920 | No | 4 | S | Direct | |
Common Stock | Disposition | 2013-09-25 | 12,000 | $1.61 | 10,967,920 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 5 | G | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 23,488 | Indirect | 401K Plan |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 1065-1 trading plan adopted by the reporting person.
- The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.35 to 1.44, inclusive. The reporting person undertakes to provide the staff of the SEC, upon request full information reporting the number of shares sold at each separate price within the ranges set forth in footnotes 2 through 4.
- The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.40 to $1.55, inclusive.
- The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.47 to $1.70, inclusive.